The novel research effort comes against the backdrop of a series of failures in other attempts to fight Alzheimer's.
They offer a route to more affordable cancer care at a time when the price of modern therapies to fight tumors is going through the roof.
The Japanese company will co-develop an early-stage medicine for Parkinson's disease.
AstraZeneca's drug cut the risk by 29 percent in patients who had past heart attacks.
AI robots are turbo-charging the race to find new drugs for ALS, also known as Lou Gehrig's disease.
Robots may be a better way for your baby boomer clients to replace their knees as they wear out.
The IMF chief worries Trump plans could spark reactions.
Please log back in before proceeding.
There was an error logging in. Please try again.
Congrats! You are now logged in. Your exam is being submitted.
